Vitreoretinopathy, Proliferative
Showing 1 - 25 of 523
Rhegmatogenous Retinal Detachment, Proliferative Vitreoretinopathy Trial (Netarsudil Ophthalmic)
Not yet recruiting
- Rhegmatogenous Retinal Detachment
- Proliferative Vitreoretinopathy
- Netarsudil Ophthalmic
- (no location specified)
Sep 9, 2023
Retinal Detachment, Proliferative Vitreoretinopathy Trial (Control group, Intervention group)
Not yet recruiting
- Retinal Detachment
- Proliferative Vitreoretinopathy
- Control group
- Intervention group
- (no location specified)
Sep 9, 2022
Rhegmatogenous Retinal Detachment, Proliferative Vitreoretinopathy Trial in Philadelphia (Netarsudil 0.02% Ophthalmic Solution
Not yet recruiting
- Rhegmatogenous Retinal Detachment
- Proliferative Vitreoretinopathy
- Netarsudil 0.02% Ophthalmic Solution [RHOPRESSA]
- Glycerin 0.2%/Hypromellose 0.2%/Peg 1%/Soln,Oph,Ud
-
Philadelphia, PennsylvaniaWills Eye Physicians - Mid Atlantic Retina
Dec 13, 2022
Retinal Detachment, Proliferative Vitreoretinopathy Trial in Banha (Pars plana vitrectomy)
Recruiting
- Retinal Detachment
- Proliferative Vitreoretinopathy
- Pars plana vitrectomy
-
Banhā, QA, EgyptAhmed Abdelshafy
Sep 28, 2022
Retinal Detachment With Multiple Breaks, Unspecified Eye, Proliferative Vitreoretinopathy Trial in Philadelphia (Intravitreal
Recruiting
- Retinal Detachment With Multiple Breaks, Unspecified Eye
- Proliferative Vitreoretinopathy
- Intravitreal aflibercept injection
- Sham control
-
Philadelphia, PennsylvaniaWills Eye Hospital
May 2, 2022
Rhegmatogenous Retinal Detachment, Proliferative Vitreoretinopathy, Retinal Detachment Trial in Cairo (Intravitreal infliximab,
Recruiting
- Rhegmatogenous Retinal Detachment
- +2 more
- Intravitreal infliximab
- Pars plana vitrectomy
-
Cairo, EgyptCairo University
Nov 26, 2021
Rhegmatogenous Retinal Detachment, High-risk for Proliferative Vitreoretinopathy (PVR) Trial in Germany (5-fluorouracil and low
Completed
- Rhegmatogenous Retinal Detachment
- High-risk for Proliferative Vitreoretinopathy (PVR)
- 5-fluorouracil and low molecular weight heparin
- Placebo
-
Freiburg, BW, Germany
- +12 more
Apr 4, 2022
Retinal Detachment, Proliferative Vitreoretinopathy Trial in Madison (Bevacizumab)
Completed
- Retinal Detachment
- Proliferative Vitreoretinopathy
-
Madison, WisconsinUniversity of Wisconsin
Mar 1, 2021
Proliferative Vitreoretinopathy Trial in United States (ADX-2191 (intravitreal methotrexate 0.8%), Standard surgical care
Recruiting
- Proliferative Vitreoretinopathy
- ADX-2191 (intravitreal methotrexate 0.8%)
- Standard surgical care procedure
-
Phoenix, Arizona
- +22 more
Jan 31, 2022
Proliferative Vitreoretinopathy Trial in Palo Alto (Methotrexate)
Not yet recruiting
- Proliferative Vitreoretinopathy
-
Palo Alto, CaliforniaByers Eye Institute at Stanford University and Lucille Packard C
Mar 31, 2021
Diabetic Retinopathy Trial (slow-release dexamethasone implant)
Not yet recruiting
- Diabetic Retinopathy
- slow-release dexamethasone implant
- (no location specified)
Jun 8, 2022
Diabetic Retinopathy, Proliferative Vitreoretinopathy, Pterygium Trial in Nanjing (ocular surgery)
Unknown status
- Diabetic Retinopathy
- +3 more
- ocular surgery
-
Nanjing, Jiangsu, ChinaFirst Affiliated Hospital of Nanjing Medical University
Dec 20, 2020
Rhegmatogenous Retinal Detachment Trial (RPE cell collection and single cell heterogeneity study, Postoperative intervention,
Not yet recruiting
- Rhegmatogenous Retinal Detachment
- RPE cell collection and single cell heterogeneity study
- +2 more
- (no location specified)
Aug 19, 2020
Extensive Brilliant Blue G-Assisted Internal Limiting Membrane
Completed
- Proliferative Vitreoretinopathy
- 3D Pars Plana Vitrectomy associated with Extensive Brilliant Blue G-Assisted ILM Peeling Method
-
Buenos Aires, Capital Federal, ArgentinaCentro Oftalmologico Dr Charles
Jul 28, 2020
Adaptive Optics in PVR
Completed
- Retinal Detachment
-
London, United KingdomMoorfields Eye Hospital NHS Foundation Trust
Sep 7, 2020
Diabetic Retinopathy, Vitreomacular Traction Trial in Minya (Methotrexate 25 MG/ML, parsplana vitrectomy)
Recruiting
- Diabetic Retinopathy
- Vitreomacular Traction
- Methotrexate 25 MG/ML
- parsplana vitrectomy
-
Minya, Minia, Egyptophthalmology department, Minia university hospital
Sep 8, 2023
Retinal Detachment Trial in Minya (Double tamponade)
Completed
- Retinal Detachment
- Double tamponade
-
Minya, EgyptMinia University
Nov 18, 2019
Retinal Detachment Trial in Bern (ILM (inner limiting membrane) peeling)
Enrolling by invitation
- Retinal Detachment
- ILM (inner limiting membrane) peeling
-
Bern, SwitzerlandBerner Augenklinik am Lindenhofspital
Mar 2, 2022
Redetachment Under Densiron for RD Multiple Breaks
Completed
- Retinal Detachment Multiple Breaks
- Densiron-68 (heavy silicone oil) tamponade for retinal detachment
-
Cairo, EgyptKasr alainy faculty of medicine
Jan 29, 2023
Eye Injury Trauma Trial in London (Triamcinolone Acetonide)
Completed
- Eye Injury Trauma
- Triamcinolone Acetonide
-
London, United KingdomMoorfields Eye Hospital
Sep 16, 2021
Retinal Redetachment After Silicone Oil Removal :Risk Factor
Completed
- Retinal Redetachment After Silicone Oil Removal
- no intervention
-
Vandœuvre-lès-nancy, FranceCHRU Nancy Brabois
Dec 4, 2022
Retinal Detachment Trial (Pars plana vitrectomy, Pars plana vitrectomy with scleral buckle, Sulfur hexafluoride gas tamponade)
Not yet recruiting
- Retinal Detachment
- Pars plana vitrectomy
- +3 more
- (no location specified)
May 16, 2023
Proliferative Vitreoretinopathy Trial in Philadelphia (Isotretinoin)
Completed
- Proliferative Vitreoretinopathy
-
Philadelphia, PennsylvaniaWills Eye Institute
Apr 30, 2018
Pro-permeability and Pro-fibrosis Factors in Aqueous of Retinal
Terminated
- Macular Edema
- Fibrosis of the Retina
- Ozurdex
- +2 more
-
Baltimore, MarylandWilmer Eye Institute
Jul 5, 2022
Diabetic Retinopathy, Retinal Detachment Trial in Montemorelos (PPV/SO, PPV/C3F8)
Completed
- Diabetic Retinopathy
- Retinal Detachment
- PPV/SO
- PPV/C3F8
-
Montemorelos, Nuevo Leon, MexicoHospital La Carlota
Nov 20, 2021